- US12421209utility2025Compounds0 cites
- US12421211utility2025Heterocyclic Compounds0 cites
- US12416631utility2025Immunoassay-based Determination of In-solution Binding Kinetics0 cites
- US12408862utility2025Digital Biomarker0 cites
- US12398203utility2025Method for Producing Bispecific Antibodies Comprising a Y436A Fc-region Mutation for Improved Protein A-binding0 cites
- US12391757utility2025Bispecific Antibodies Specific for PD1 and TIM30 cites
- US12378315utility2025Anti-rabbit CD19 Antibodies and Methods of Use0 cites
- US12371748utility2025Genetic Markers for Predicting Responsiveness to Therapy with Hdl-raising or HDL Mimicking Agent0 cites
- US12372537utility2025Determination of Parkinson's Disease0 cites
- US12365687utility2025Benzodiazepine Derivatives as GABA a Gamma 1 PAM0 cites
- US12357748utility2025Microdosing0 cites
- US12358997utility2025Bispecific Anti-human A-beta/anti-human Transferrin Receptor Antibodies0 cites
- US12360123utility2025E3 Ubiquitin Ligase (UBE3A) Protein Targets0 cites
- US12350273utility2025Treatment of SMA0 cites
- US12351575utility20256-fused Heteroaryldihydropyrimidines for the Treatment and Prophylaxis of Hepatitis B Virus Infection0 cites
- US12343310utility2025Device for Transferring a Liquid from a First Vial to a Second Vial0 cites
- US12344613utility2025EGFR Inhibitor for the Treatment of Cancer0 cites
- US12344614utility2025Benzodiazepine Derivatives as GABA a GAMMA1 PAM0 cites
- US12345711utility2025Methods to Determine Antibody Activity in Tumor Samples0 cites
- US12338456utility2025Method for Increasing the Specific Production Rate of Eukaryotic Cells0 cites